VALFIX Medical is developing a complete trans-catheter solution whose multi-wire technology combines repair and replacement treatments for the mitral and the tricuspid valves, offering a viable alternative to open heart surgery.
Its technology is designed to eliminate mitral regurgitation (MR) in over 90% of severe MR patients.VALFIX Medical is creating a solution designed to be the closest to the surgical standard in trans-catheter mitral valve repair and replacement.